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In fish, DNA vaccines encoding the glycoproteins (G proteins) of the salmonid rhabdoviruses 
VHSV and IHNV have proved very efficient under experimental conditions. Nano-gram amounts of 
plasmid DNA can induce long-lasting protective immunity when delivered by intramuscular 
injection in rainbow trout fingerlings. Vaccination of fish at an early stage appears advantageous, 
since larger fish require higher doses of vaccine to be protected. Even in fish with an average size of 
0.5 g at the time of vaccination, good protection can be obtained. Interestingly, immunity is 
established already a few days after vaccination and cross-challenge experiments have revealed that 
protection in the early phase is non-specific. Later on, protection becomes very specific in terms of 
virus species. The protection in the early non-specific phase is related to interferon induced defence 
mechanisms whereas specific antibodies and cellular components both play a role in the long lasting 
protection. The similarity of the functional immune response profile to that induced by a natural 
virus infection is striking and is most likely one of the major reasons for the efficacy of the 
rhabdovirus DNA vaccines. Although other elements like CpG motifs in the plasmid backbone 
sequence might play a role, the viral G protein appears to have an inherent ability to stimulate 
innate immune mechanisms by receptors and pathways that still remain to be characterized in detail. 
Immunity to VHS in rainbow trout can be induced by DNA vaccination across a temperature range 
of at least 5-15°C. Interestingly, the initial non-specific phase is significantly prolonged at lower 
temperatures, hereby ensuring protection despite a slow activation of adaptive mechanisms. 
Expression of the rhabdovirus G protein on the surface of transfected muscle cells induces a 
histologically visible local inflammatory reaction with higher doses of VHSV G DNA vaccine. Cell 
surface expression may be important for a proper activation of the fish immune system, since 
blocking of the intracellular trafficking of the expressed glycoprotein G-gene interferes with 
protection. It may be anticipated that the viral G protein acts like a PAMP (pathogen associated 
molecular pattern), but it remains to be determined which PRRs (pattern recognition receptors) that 
may be involved in the recognition of the G protein. Recent data from DNA vaccination trials with 
variant forms of the G protein gene suggest that the structural requirements for antigenicity are 
different from the requirements for immunogenicity.  
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